Nilotinib: A Tyrosine Kinase Inhibitor Mediates Resistance to Intracellular Mycobacterium Via Regulating Autophagy

Nilotinib, a tyrosine kinase inhibitor, has been studied extensively in various tumor models; however, no information exists about the pharmacological action of nilotinib in bacterial infections. Mycobacterium bovis (M. bovis) and Mycobacterium avium subspecies paratuberculosis (MAP) are the etiolog...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cells
Главные авторы: Hussain, Tariq, Zhao, Deming, Shah, Syed Zahid Ali, Sabir, Naveed, Wang, Jie, Liao, Yi, Song, Yinjuan, Dong, Haodi, Hussain Mangi, Mazhar, Ni, Jiamin, Yang, Lifeng, Zhou, Xiangmei
Формат: Artigo
Язык:Inglês
Опубликовано: MDPI 2019
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC6562972/
https://ncbi.nlm.nih.gov/pubmed/31130711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells8050506
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы